{
    "Trade/Device Name(s)": [
        "EasyGluco Plus Blood Glucose Monitoring System"
    ],
    "Submitter Information": "US Diagnostics, Inc.",
    "510(k) Number": "K110435",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082201"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "September 21, 2011",
    "Summary Letter Received Date": "August 26, 2011",
    "Submission Date": "August 22, 2011",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "EasyGluco Plus Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for EasyGluco Plus Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various sites as an aid in monitoring diabetes management at home by single patients; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}